Cargando…

Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation

PURPOSE: A palmitoylated prodrug of emtricitabine (FTC) was synthesized to extend the drug’s half-life, antiretroviral activities and biodistribution. METHODS: A modified FTC prodrug (MFTC) was synthesized by palmitoyl chloride esterification. MFTC’s chemical structure was evaluated by nuclear magne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Ibrahim M, Bade, Aditya N, Lin, Zhiyi, Soni, Dhruvkumar, Wojtkiewicz, Melinda, Dyavar Shetty, Bhagya Laxmi, Gautam, Nagsen, McMillan, JoEllyn M, Alnouti, Yazen, Edagwa, Benson J, Gendelman, Howard E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689761/ https://www.ncbi.nlm.nih.gov/pubmed/31496683 http://dx.doi.org/10.2147/IJN.S215447

Ejemplares similares

ProTide generated long-acting abacavir nanoformulations
por: Lin, Zhiyi, et al.
Publicado: (2018)

Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
por: Zhou, Tian, et al.
Publicado: (2017)

A Year-Long Extended Release Nanoformulated Cabotegravir Prodrug
por: Kulkarni, Tanmay A., et al.
Publicado: (2020)

Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques
por: McMillan, JoEllyn, et al.
Publicado: (2017)

Creation of a Long-Acting Nanoformulated 2′,3′-Dideoxy-3′-Thiacytidine
por: Guo, Dongwei, et al.
Publicado: (2017)

Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles
por: Cobb, Denise A., et al.
Publicado: (2021)

Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
por: Gautam, Nagsen, et al.
Publicado: (2021)

Creation of a long-acting nanoformulated dolutegravir
por: Sillman, Brady, et al.
Publicado: (2018)

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
por: Deodhar, Suyash, et al.
Publicado: (2022)

Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals
por: Zhou, Tian, et al.
Publicado: (2018)

Nanoformulated Antiretroviral Therapy Attenuates Brain Metabolic Oxidative Stress
por: Montenegro-Burke, J. Rafael, et al.
Publicado: (2018)

Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
por: Kanmogne, Georgette D, et al.
Publicado: (2012)

Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment
por: Bade, Aditya N., et al.
Publicado: (2021)

Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy
por: Martinez-Skinner, Andrea L., et al.
Publicado: (2015)

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
por: Balkundi, Shantanu, et al.
Publicado: (2010)

Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages
por: Araínga, Mariluz, et al.
Publicado: (2015)

Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution
por: Kevadiya, Bhavesh D., et al.
Publicado: (2018)

Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes
por: Edagwa, Benson J., et al.
Publicado: (2014)

Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis
por: Shahnaz, Gul, et al.
Publicado: (2017)

Comparative manufacture and cell-based delivery of antiretroviral nanoformulations
por: Balkundi, Shantanu, et al.
Publicado: (2011)

Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy
por: Li, Tianyuzi, et al.
Publicado: (2015)

Prodrug Therapies for Infectious and Neurodegenerative Diseases
por: Markovic, Milica, et al.
Publicado: (2022)

Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues
por: Kevadiya, Bhavesh D., et al.
Publicado: (2020)

Pharmacotherapeutics of SARS-CoV-2 Infections
por: Kevadiya, Bhavesh D., et al.
Publicado: (2021)

Bile acid indices as biomarkers for liver diseases I: Diagnostic markers
por: Alamoudi, Jawaher Abdullah, et al.
Publicado: (2021)

Bile acid indices as biomarkers for liver diseases II: The bile acid score survival prognostic model
por: Alamoudi, Jawaher Abdullah, et al.
Publicado: (2021)

An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression
por: Das, Srijanee, et al.
Publicado: (2022)

EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment
por: Gu, Chao-Jiang, et al.
Publicado: (2018)

Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases
por: Li, Wenkuan, et al.
Publicado: (2022)

Inhibition of matrix metalloproteinases by HIV-1 integrase strand transfer inhibitors
por: Foster, Emma G., et al.
Publicado: (2023)

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
por: Boska, Michael, et al.
Publicado: (2010)

Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations
por: Curley, Paul, et al.
Publicado: (2023)

The Synergistic Effect of an ATP-Competitive Inhibitor of mTOR and Metformin on Pancreatic Tumor Growth
por: Soliman, Ghada A, et al.
Publicado: (2020)

Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice
por: Dash, Prasanta K., et al.
Publicado: (2019)

Direct Comparison of Chol-siRNA Polyplexes and Chol-DsiRNA Polyplexes Targeting STAT3 in a Syngeneic Murine Model of TNBC
por: Ye, Zhen, et al.
Publicado: (2022)

Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide
por: Sax, Paul E., et al.
Publicado: (2018)

Linear and branched polymer prodrugs of the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine as structural materials for long-acting implants
por: Shakil, Anika, et al.
Publicado: (2022)

CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination
por: Herskovitz, Jonathan, et al.
Publicado: (2021)

A Link Between Methylglyoxal and Heart Failure During HIV-1 Infection
por: Dash, Prasanta K., et al.
Publicado: (2021)

Local Delivery of Azithromycin Nanoformulation Attenuated Acute Lung Injury in Mice
por: Alrashedi, Mohsen G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p8n95ht6pl1agkfk2nlh7kkp7m